Protagonist Therapeutics Inc (PTGX)
30.11
-0.30
(-0.99%)
USD |
NASDAQ |
May 28, 11:44
Protagonist Therapeutics Cash from Operations (Quarterly): -27.43M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -27.43M |
| December 31, 2023 | 16.96M |
| September 30, 2023 | -26.61M |
| June 30, 2023 | -26.24M |
| March 31, 2023 | -34.35M |
| December 31, 2022 | -31.64M |
| September 30, 2022 | -25.20M |
| June 30, 2022 | -13.64M |
| March 31, 2022 | -37.67M |
| December 31, 2021 | -26.94M |
| September 30, 2021 | -28.47M |
| June 30, 2021 | -23.70M |
| March 31, 2021 | -28.76M |
| December 31, 2020 | -18.87M |
| September 30, 2020 | -16.29M |
| June 30, 2020 | -21.48M |
| March 31, 2020 | -15.85M |
| December 31, 2019 | -14.29M |
| September 30, 2019 | -14.25M |
| Date | Value |
|---|---|
| June 30, 2019 | 3.67M |
| March 31, 2019 | -16.66M |
| December 31, 2018 | -10.14M |
| September 30, 2018 | -9.276M |
| June 30, 2018 | -15.40M |
| March 31, 2018 | -15.14M |
| December 31, 2017 | -14.15M |
| September 30, 2017 | 40.70M |
| June 30, 2017 | -12.33M |
| March 31, 2017 | -10.36M |
| December 31, 2016 | -9.68M |
| September 30, 2016 | -6.98M |
| June 30, 2016 | -8.073M |
| March 31, 2016 | -5.239M |
| December 31, 2015 | -4.739M |
| September 30, 2015 | -3.769M |
| June 30, 2015 | -3.444M |
| March 31, 2015 | -2.433M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-37.67M
Minimum
Mar 2022
16.96M
Maximum
Dec 2023
-20.55M
Average
-24.45M
Median
Cash from Operations (Quarterly) Benchmarks
| Lifecore Biomedical Inc | -17.29M |
| SELLAS Life Sciences Group Inc | -10.76M |
| Akebia Therapeutics Inc | -19.43M |
| Immuneering Corp | -15.49M |
| Moderna Inc | -989.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.071M |
| Cash from Financing (Quarterly) | 7.199M |
| Free Cash Flow | -64.16M |
| Free Cash Flow Per Share (Quarterly) | -0.4351 |
| Free Cash Flow to Equity (Quarterly) | -27.67M |
| Free Cash Flow to Firm (Quarterly) | -27.67M |
| Free Cash Flow Yield | -3.55% |